Kalaris Therapeutics KLRS
NASDAQ KLRS
$1.90 +0.03 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Kalaris Therapeutics (KLRS) Depreciation and Depletion (2025 - 2026)

Updated

Kalaris Therapeutics' Depreciation and Depletion was $10,000 in Q2 2026, unchanged from the prior quarter.

Analysis

Kalaris Therapeutics (KLRS) Depreciation and Depletion (2025 - 2026) Analysis & Trends

For FY2025, Depreciation and Depletion at Kalaris Therapeutics came in at $13,000.

  • Depreciation and Depletion shows a five-year compound annual growth rate of -33.5% (FY2020 to FY2025).
  • In earlier years, Depreciation and Depletion was $400,000 in FY2023 (-42.9%), $700,000 in FY2022 (+250.0%) and $200,000 in FY2021 (+100.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 192.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 726.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 132.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Kalaris Therapeutics 44.52 Mn -38.38 Mn - 10,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 10,000.00
Jun 30, 2026 10,000.00
Mar 31, 2026 10,000.00
Dec 31, 2025 10,000.00
API Access

Kalaris Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=KLRS&period=max&api_key=YOUR_API_KEY